[Disclosure] Celltrion (068270) – Final Marketing Authorization Granted by European Commission (EC) for Omlyclo (CT-P39, Xolair Biosimilar) / 2024-05-24
Fact Source: Financial Supervisory Service DART 💡 3-Second Summary Celltrion announced that it has obtained final marketing authorization from the European Commission (EC) for Omlyclo (CT-P39), a biosimilar to Xolair, covering 30 European countries for all approved indications of the reference drug. 📊 [Key Disclosure Details & Financial Highlights] 📝 Editor’s Comment (Key Follow-up Checkpoint)…